ECDC Situation risk assessment
A total of 2746 cases of monkeypox have been identified through IHR/EWRS mechanisms up to 21 June 2022, 14:00, from 29 countries and areas throughout the European region. Case-based data were reported for 1799 cases from 20 countries and areas to ECDC and the WHO Regional Office for Europe through The European Surveillance System (TESSy), up to 21 June 2022, 10:00.
Of the 1799 cases reported in TESSy, 1796 were laboratory confirmed. 21 were confirmed to be of the West African clade. The earliest date of symptom onset was reported as 08 April 2022. The majority of cases were between 31 and 40 years-old (792/1796 - 44.1%) and male (1761/1771 - 99.4%). Among cases with known HIV status, 115/281 - 40.9% were HIV-positive. No cases were reported to have died. So far 5 health care workers were notified as cases in TESSy. None are known to have acquired infection through occupational exposure to date.
This report provides an overview of the total number of cases of monkeypox identified by ECDC and the WHO Regional Office for Europe through IHR/EWRS mechanisms and case-based data through The European Surveillance System (TESSy) up to 21 May 2022.
The first summary table describes the number of cases identified through the different platforms. The following figures and tables describe national case-based data for surveillance of monkeypox reported in TESSy from all the countries and areas of the WHO European Region, including the 27 countries of the European Union (EU) and the additional three countries of the European Economic Area (EEA).
Case Report Form Data are submitted through the case-based record type MPX to The European Surveillance System (TESSy) database hosted at ECDC.
Cases of monkeypox should be reported to TESSy if they meet any of the WHO or ECDC case definitions.
AND One or more of the following:
AND one or more of the following signs or symptoms, since 15 March 2022:
AND for which the following common causes of acute rash do not explain the clinical picture:
AND one of the following:
OR
*Since EU/EEA countries are just starting to identify cases and if testing capacity is sufficient, the above more sensitive case definition can be used. In countries with limited testing capacity for orthopoxviruses, the following description can be added to characterize the rash: ‘unexplained localized or generalized maculopapular or vesiculopustular rash potentially with umbilication or scabbing’.
**Fever (usually higher >38.5°C), headache, back ache, fatigue, lymphadenopathy (localized or generalized).
Summary of number of cases of monkeypox identified through IHR/EWRS mechanisms and reported to TESSy, European Region, 2022
Overall number of cases of monkeypox, per date of symptom onset, European Region, TESSy, 2022
Number of cases of monkeypox, per day and per country/area of notification, European Region, TESSy, 2022
Number of cases of monkeypox, per day and per country/area of notification, European Region, TESSy, 2022
*Day of symptom onset or earliest of day of diagnosis or notification if missing
Summary of number of probable and confirmed cases of monkeypox by reporting country/area, European Region, TESSy, 2022
Age and sex distribution of cases of monkeypox, European Region, TESSy, 2022
Information on sex is missing for 28 cases and information on age is missing for 3 cases.
Distribution of symptoms among those reporting at least one type of symptoms (N=660), European Region, TESSy, 2022
*Fever, fatigue, muscle pain, vomiting, diarrhea, chills, sore throat, headache
Detection of asymptomatic cases is dependent on testing guidelines which currently do not recommend testing asymptomatic persons
Summary of outcome, HIV status, and cases of monkeypox among health care workers, European Region, TESSy, 2022
*Includes cases hospitalized for isolation or treatment (13 cases were hospitalized for isolation purposes,10 required clinical care and 12 were hospitalized for unknown reasons).
Summary of reported sexual orientations among cases of monkeypox, European Region, TESSy, 2022
Sexual orientation in TESSy is defined according to the following non-mutually exclusive categories:
Sexual orientation is not necessarily representative of the gender of the person the case had sex with in the past 21 days nor does it imply sexual contact and sexual transmission.
We summarize here the sexual orientation that male cases identified with. No differences were observed across age groups.
Summary of specimen types tested positive for monkeypox, European Region, TESSy, 2022
ECDC’s legal notice and disclaimer can be found at https://www.ecdc.europa.eu/en/legal-notice
Users are advised to interpret all data with caution and be aware of their limitations. Case counts and their corresponding data may have weekly updates that include historical corrections as new information is collected and reported.
The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of WHO or ECDC concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.
The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by WHO or ECDC in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.
All reasonable precautions have been taken by WHO and ECDC to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall WHO or ECDC be liable for damages arising from its use.
Copyright, permissions and referencing The WHO Regional Office for Europe is responsible for the accuracy of the Russian translation.
Suggested citation: European Centre for Disease Prevention and Control/WHO Regional Office for Europe. Monkeypox, Joint Epidemiological overview, 22 June, 2022.
Tables and figures should be referenced: European Centre for Disease Prevention and Control/WHO Regional Office for Europe. Monkeypox, Joint Epidemiological overview, 22 June, 2022.
© World Health Organization 2022.
© European Centre for Disease Prevention and Control 2022.
Reproduction is authorized, provided the source is acknowledged.
We gratefully acknowledge the input of national public health staff involved in surveillance activities and data submission to TESSy.